Top 20 of Leishmaniasis

Article title # Publications/# Citations

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

1989: RLCoffman; FPHeinzel; BJHoladay; RMLocksley; MDSadick;

312

Leishmaniasis worldwide and global estimates of its incidence.

2012: WHO Leishmaniasis Control Team; JAlvar; CBern; JCano; Mden Boer; PDesjeux; MHerrero; JJannin; IDVelez;

245

Advances in leishmaniasis.

2005 Oct 29-Nov 4: JDBerman; CRDavies; HWMurray; NGSaravia;

212

Heterogeneities in the transmission of infectious agents: implications for the design of control programs.

1997: RMAnderson; SKChandiwana; JDCharlwood; CDye; JFEtard; GPGarnett; PHagan; JLHii; ... PDNdhlovu; RJQuinnell; TSmith; CHWatts; MEWoolhouse;

190

Leishmaniasis.

1999: BLHerwaldt;

189

Drug resistance in leishmaniasis.

2006: SLCroft; AHFairlamb; SSundar;

183

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens.

1988: RLCoffman; PNatovitz; EPearce; PScott; ASher;

164

Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine.

1990: FYLiew; SMillott; SMoncada; RMPalmer; CParkinson;

156

Comparative genomic analysis of three Leishmania species that cause diverse human disease.

2007: EAdlem; CArrowsmith; MAslett; SLBaldauf; BBarrell; MBerriman; FBringaud; LOBrito; ... TCarver; TChillingworth; AKCruz; DPDepledge; AFaulconbridge; AFraser; ZHance; DHarris; JDHilley; AIvens; KJagels; DJeffares; AKerhornou; JCMottram; SMoule; LMurphy; HNorbertczak; DOrmond; SOOyola; CSPeacock; NPeters; MAQuail; ERabbinowitsch; MARajandream; JCRuiz; SRutter; KSeeger; DFSmith; RSquares; SThurston; ATivey; LRTosi; BWhite; SWhitehead;

146

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.

1990: RSDawkins; FPHeinzel; BJHoladay; RMLocksley; RTPu; MDSadick;

146

Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions.

1989: BRBloom; MBBrenner; FMHofman; RLModlin; CPirmez; THRea; VTorigian; KUyemura;

137

SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

1999: WSAlexander; JECorbin; ALCornish; RDarwiche; JEFenner; EHandman; PJHertzog; DJHilton; ... TWKay; DMetcalf; NANicola; CMOwczarek; CLScott; NSSprigg; RStarr;

134

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis.

1991: FPHeinzel; RMLocksley; SSMutha; MDSadick;

125

A limiting dilution assay for quantifying Leishmania major in tissues of infected mice.

1985: TBoon; JALouis; MMarchand; RGTitus;

116

The relationship between leishmaniasis and AIDS: the second 10 years.

2008: JAlvar; PAparicio; AAseffa; CCañavate; JPDedet; Mden Boer; LGradoni; RLópez-Vélez; JMoreno; Rter Horst;

108

Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha.

1990: RMCrawford; SJGreen; JTHockmeyer; MSMeltzer; CANacy;

107

Identification of an infective stage of Leishmania promastigotes.

1984: PVPerkins; DLSacks;

104

Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide.

1990: YLi; FYLiew; SMillott;

99

The increase in risk factors for leishmaniasis worldwide.

2001 May-Jun: PDesjeux;

97

Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.

1989: MBelosevic; DSFinbloom; CANacy; MVSlayter; PHvan der Meide;

95